S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Tesla cuts US prices for 3 of its electric vehicle models after a difficult week
A coffee roastery in Finland has launched an AI-generated blend. The results were surprising
Autoworkers union celebrates breakthrough win in Tennessee and takes aim at more plants in the South
New York lawmakers pass $237 billion budget with policies to jump-start housing market
The House votes for possible TikTok ban in the US, but don't expect the app to go away anytime soon
Hawaii lawmakers take aim at vacation rentals after Lahaina wildfire amplifies Maui housing crisis
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
OTCMKTS:SSMXY

Sysmex (SSMXY) Stock Price, News & Analysis

$15.02
-0.68 (-4.33%)
(As of 04/19/2024 ET)
Today's Range
$15.02
$15.12
50-Day Range
$15.02
$18.83
52-Week Range
$15.02
$36.57
Volume
40,994 shs
Average Volume
47,894 shs
Market Capitalization
$9.45 billion
P/E Ratio
29.65
Dividend Yield
0.87%
Price Target
N/A
SSMXY stock logo

About Sysmex Stock (OTCMKTS:SSMXY)

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

SSMXY Stock Price History

SSMXY Stock News Headlines

Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Grows By 30.0%
Sysmex Corp. ADR
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Sysmex Corp.
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
Sysmex Corp ADR SSMXY
Roche expands long-term alliance with Sysmex
Sysmex America gets new finance chief
Sysmex America Names Chris Cappella as Chief Financial Officer
See More Headlines
Receive SSMXY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sysmex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/09/2024
Today
4/21/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:SSMXY
Employees
10,522
Year Founded
1968

Profitability

Net Income
$338.80 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.04 billion
Cash Flow
$0.87 per share
Book Value
$4.57 per share

Miscellaneous

Free Float
N/A
Market Cap
$9.45 billion
Optionable
Not Optionable
Beta
0.66

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Hisashi Ietsugu (Age 75)
    Chairman of the Managing Board & Group CEO
    Comp: $1.48M
  • Mr. Kaoru Asano (Age 66)
    President & Representative Director
  • Mr. Chris Cappella
    Chief Financial Officer
  • Mr. Tomokazu Yoshida (Age 60)
    Managing Executive Officer, CTO & Member of the Managing Board
  • Mr. Frank Buescher
    Senior Executive Officer
  • Mr. Iwane Matsui (Age 63)
    Senior Managing Executive Officer & Member of the Managing Board
  • Mr. Kenji Tachibana (Age 67)
    Sr. MD of Corp Mgmt & Regulatory Affairs, Sr. Exec. Officer & Member of the Managing Board
  • Mr. Mamoru Kubota
    Senior Executive Officer
  • Mr. Kensuke Iizuka
    Senior Executive Officer & Executive VP of Corporate Business Planning Div.
  • Mr. Zuo Hui Peng
    Executive Officer

SSMXY Stock Analysis - Frequently Asked Questions

How have SSMXY shares performed in 2024?

Sysmex's stock was trading at $18.5067 at the start of the year. Since then, SSMXY stock has decreased by 18.8% and is now trading at $15.02.
View the best growth stocks for 2024 here
.

Are investors shorting Sysmex?

Sysmex saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 6,500 shares, an increase of 30.0% from the March 15th total of 5,000 shares. Based on an average trading volume of 40,500 shares, the days-to-cover ratio is presently 0.2 days.
View Sysmex's Short Interest
.

How were Sysmex's earnings last quarter?

Sysmex Co. (OTCMKTS:SSMXY) announced its quarterly earnings data on Friday, February, 9th. The company reported $0.13 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.16 by $0.03. The business earned $770.84 million during the quarter. Sysmex had a net margin of 10.25% and a trailing twelve-month return on equity of 11.15%.

Is Sysmex a good dividend stock?

Sysmex (OTCMKTS:SSMXY) pays an annual dividend of $0.13 per share and currently has a dividend yield of 0.86%. The dividend payout ratio is 25.66%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SSMXY will have a dividend payout ratio of 20.31% next year. This indicates that the company will be able to sustain or increase its dividend.

When did Sysmex's stock split?

Sysmex's stock split on the morning of Tuesday, April 2nd 2024. The 1.5-1 split was announced on Tuesday, April 2nd 2024. The newly minted shares were issued to shareholders after the market closes on Tuesday, April 2nd 2024. An investor that had 100 shares of stock prior to the split would have 150 shares after the split.

How do I buy shares of Sysmex?

Shares of SSMXY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Sysmex have any subsidiaries?
The following companies are subsidiares of Sysmex: HITADO GmbH, HYPHEN BioMed SAS, Jinan Sysmex Medical Electronics Co. Ltd., Medicaroid Corporation, PT.Sysmex Indonesia, RIKEN GENESIS CO. LTD., Sysmex (Malaysia) Sdn Bhd, Sysmex (Thailand) Co. Ltd., Sysmex America Inc., Sysmex Asia Pacific Pte Ltd., Sysmex Australia Pty Ltd., Sysmex Austria GmbH, Sysmex Belgium N.V., Sysmex Business Support Co. Ltd., Sysmex CNA Co. Ltd., Sysmex CZ s.r.o., Sysmex Canada Inc., Sysmex Colombia SAS, Sysmex Deutschland GmbH, Sysmex Diagnósticos México S. de R.L. de C.V., Sysmex Engineering Co. Ltd., Sysmex Espana S.L., Sysmex Europe GmbH, Sysmex France S.A.S., Sysmex Hong Kong Limited, Sysmex Hungaria Kft., Sysmex India Pvt. Ltd., Sysmex Inostics GmbH, Sysmex Inostics Inc., Sysmex International Reagents Co. Ltd., Sysmex Korea Co. Ltd., Sysmex Latin America & the Caribbean, Sysmex Medica Co. Ltd., Sysmex Middle East FZ - LLC, Sysmex Nederland B.V., Sysmex New Zealand Limited, Sysmex Nordic ApS, Sysmex Norge, Sysmex Partec GmbH, Sysmex Philippines Inc., Sysmex Polska Sp.z o.o., Sysmex RA Co. Ltd., Sysmex RUS LLC, Sysmex Reagents America Inc., Sysmex Shanghai Ltd., Sysmex Slovakia s.r.o., Sysmex South Africa (Pty) Ltd., Sysmex Suisse AG, Sysmex Sverige, Sysmex TAIWAN Co. Ltd., Sysmex TMC Co. Ltd., Sysmex Transasia Services Pvt Ltd., Sysmex Turkey Diagnostik Sistemleri Ltd. Sti., Sysmex UK Limited, Sysmex Vietnam Company Limited, Sysmex West and Central Africa Ltd., Sysmex Wuxi Co. Ltd., Sysmex bioMérieux Co. Ltd., and Sysmex do Brasil Indústria e Comércio Ltda..
Read More
This page (OTCMKTS:SSMXY) was last updated on 4/21/2024 by MarketBeat.com Staff

From Our Partners